Results of Annual Meeting
28 Maio 2009 - 11:48AM
UK Regulatory
TIDMRPSE
RNS Number : 9764S
Research Pharmaceutical SRV, Inc
28 May 2009
28 May 2009
ReSearch Pharmaceutical Services, Inc.
Results of Annual Meeting
ReSearch Pharmaceutical Services, Inc. ("RPS" or the "Company"), a leading
provider of integrated clinical development outsourcing solutions to the
bio-pharmaceutical industry, is pleased to announce the results of its Annual
Meeting of Stockholders held at its corporate headquarters yesterday, Wednesday
May 27, 2009.
The Board is pleased to announce that all resolutions relating to the common
stock were approved by stockholders at the Annual Meeting.
Resolution 1, electing three Class II directors to our Board, passed. Jack
Dean, Warren Myers and Daniel Raynor were elected to the board unanimously and
are due for re-election at our annual meeting in 2012.
Resolution 2 passed, ratifying the appointment of Ernst & Young, LLP as the
independent auditors for RPS for the 2009 fiscal year.
Full details of the resolutions were set out in the Notice of Annual Meeting,
which was sent to stockholders on or about April 30, 2009 and are available on
the Company's website, www.rpsweb.com. Resolutions 1 and 2 were ordinary
resolutions, requiring more than 50% of stockholders' votes to be cast for the
resolutions.
For further information please contact:
+--------------------------------------------+----------------------------+
| ReSearch Pharmaceutical Services, Inc. | +1 215 540 0700 |
+--------------------------------------------+----------------------------+
| Dan Perlman, CEO | |
+--------------------------------------------+----------------------------+
| Steven Bell, Chief Financial Officer | |
+--------------------------------------------+----------------------------+
| | |
+--------------------------------------------+----------------------------+
| Nominated Adviser and UK Broker: | |
+--------------------------------------------+----------------------------+
| Arbuthnot Securities Limited | |
+--------------------------------------------+----------------------------+
| James Steel / Ed Burbidge | +44 20 7012 2000 |
+--------------------------------------------+----------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGAPMITMMITBFL
Res.Phm.Reg S (LSE:RPSE)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Res.Phm.Reg S (LSE:RPSE)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Res.Phm.Reg S da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Res.Phm.Reg S